Experimental brain tumor therapy offered before approval
NCT ID NCT07497984
Summary
This program provides eligible patients with access to an investigational drug called ITM11 for treating meningioma, a type of brain tumor, before it is officially approved. A treating doctor must decide if the potential benefits for an individual patient outweigh the risks of using an unapproved therapy. The program's availability depends on the patient's country and specific eligibility criteria.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.